This seminar will address several of today’s key challenges in drug development leading up to clinical proof of concept.
The agenda brings together a panel of speakers from academia, pharmaceutical companies and solution providers to discuss key issues from formulation design right through to effective clinical trial planning.
The final session w ill discuss how to create the optimum development package for drug licensing; a crucial consideration for many companies, and w ill include both large and small company perspectives on the best w ays to achieve this.
Date & Time: 28 February 2012, 9.30 – 15.30
Venue: Arne Jacobsens Allé 15-17, 2300 Copenhagen S, Denmark
Price: Participations is free how ever registration is required.
Who Should Attend?
The seminar is intended for anyone w orking in the early development arena from formulation development through to clinical proof of concept. It will be an excellent opportunity to meet, exchange ideas and netw ork w ith other industry colleagues.
The event is free but attendees w ill be required to register by follow ing the link on the right. Be informed that the number of places is limited!
|9.30||Welcome Coffee & Participant Registration from|
|10.00||Recent advances in the oral delivery of biomolecules by Associate Professor Hanne Mørck Nielsen, University of Copenhagen|
|10.40||Candidate selection and formulation screening by Dr. Brian Henry, Pfizer|
|11.20||In-vitro methods to predict the in vivo performance of enabling formulations by Associate Professor Anette Mullertz, University of Copenhagen|
|13.00||Generating meaningful clinical data early; effective clinical trial design by Professor Henning Blume, Socratec|
|13.40||Simple manufacturing solutions for small and large scale clinical studies by Dr. Sven Stegemann, Capsugel|
|14.20||Licensing your drug; What is the right development package? Industry Perspectives from Pharma and Biotech|